SANOFI CONSUMER HEALTHCARE INDIA
|
The Current P/S Ratio of SANOFI CONSUMER HEALTHCARE INDIA is 9.62.
| Share Price | ₹3,972.8 | Sep 24,2026 |
| Market Cap | ₹9,137.3 Cr | |
| Sales-TTM | ₹949.8 Cr | TTM-Standalone Results |
| Price/Sales | 9.62x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SANOFI CONSUMER HEALTHCARE INDIA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹9,137.3 Cr] as on Sep 24,2026
(/) Sales [ ₹949.8 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 9.62x ]
Thus, for SANOFI CONSUMER HEALTHCARE INDIA , the investors are currently willing to pay '9.62 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SANOFI CONSUMER HEALTHCARE INDIA !
The chart below summarizes the trend in P/S Ratio of SANOFI CONSUMER HEALTHCARE INDIA over the last five years.
Historical PS (Price/Sales) ratio chart of SANOFI CONSUMER HEALTHCARE INDIA
PS Ratio Performance Analysis for SANOFI CONSUMER HEALTHCARE INDIA
- SANOFI CONSUMER HEALTHCARE INDIA 's p/e ratio for fiscal years ending Dec2025 to Dec2023 averaged 9.16x.
- SANOFI CONSUMER HEALTHCARE INDIA 's operated at median p/e ratio of 11.85x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, SANOFI CONSUMER HEALTHCARE INDIA 's p/e ratio peaked in Dec2024 at 15.64x.
- SANOFI CONSUMER HEALTHCARE INDIA 's p/e ratio hit its five-year low in Dec2023 of 0x.
How does SANOFI CONSUMER HEALTHCARE INDIA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SANOFI CONSUMER HEALTHCARE INDIA | 949.8 | 9.62 | 9,137.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.42 | 444,597.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 22.72 | 255,195.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.94 | 187,712.0 |
| CIPLA LTD | 28,324.4 | 4.00 | 113,423.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 3.02 | 100,195.0 |
| MANKIND PHARMA LTD | 14,737.9 | 6.94 | 102,229.0 |
| LUPIN LTD | 29,966.6 | 3.20 | 95,939.4 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.12 | 117,705.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.83 | 98,965.0 |
| LAURUS LABS LTD | 7,269.6 | 15.06 | 109,481.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SANOFI CONSUMER HEALTHCARE INDIA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.83x |
| Max industry PS | 22.72x |
| Median industry PS | 6.94x |
| Average industry PS | 8.26x |
You may also like the below Video Courses